Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
IM ›
IMENVEO
Trademark search for:
IMENVEO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2008-07-11 — Application filed
2008-08-21 — Sn assigned for sect 66a appl from ib
2008-08-22 — Application filed
2008-09-15 — Assigned to examiner
2008-09-16 — Final disposition recorded
2008-09-17 — Office action issued
2008-09-17 — Office action issued
2008-09-17 — Office action issued
2008-10-10 — Office action issued
2008-11-17 — Office action issued
2008-11-28 — Teas/email correspondence entered
2008-11-28 — Assigned to lie
2008-11-28 — Correspondence received in law office
2008-12-04 — Approved for pub - principal register
2008-12-05 — Law office publication review completed
2008-12-24 — Notice of publication
2009-01-13 — Published for opposition
2009-03-26 — New representative at ib received
2009-03-31 — Registered-principal register
2009-04-24 — Teas change of correspondence received
2009-07-01 — Final disposition recorded
2009-07-09 — Change of name/address rec'd from ib
2009-07-20 — Final disposition recorded
2009-07-20 — Final disposition recorded
2009-10-10 — Final disposition recorded
2013-04-28 — New representative at ib received
2015-07-03 — Change of owner received from ib
2015-11-06 — Cancelled section 71
2016-07-06 — Total invalidation of reg ext protection created
2016-07-06 — Total invalidation of reg ext protection sent to ib
2016-07-06 — Invalidation processed
2017-04-14 — Total invalidation processed by the ib
2018-07-11 — Final status recorded
2019-02-08 — Death of international registration
2019-02-08 — Notification of effect of cancellation of intl reg mailed
Owner Information
Glaxosmithkline Biologicals S.A.
Novartis AG
NOVARTIS AG
NOVARTIS AG
Correspondent
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
